An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the ...

Belief in the perceived effectiveness of the treatment (ρ 0.52, 95% CI 0.40-0.63, P <0.001) and confidence in their ability ...

Researchers writing in The Lancet review breakthroughs in type 1 diabetes treatment, from immunotherapies that delay onset to ...

Oncotelic herapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of oncology and immunotherapy products. The Company’s mission is to address high-unmet-need cancers ...

When Laura Ehrlich gave birth to her first child in 2020, the COVID-causing virus wasn’t the only threat facing her son. Born ...

The U.S. Food and Drug Administration (FDA) has approved the subcutaneous form of Keytruda for a new 'Under-the-Skin' Option ...

A tragic RSV vaccine trial in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in ...

The F.D.A. announced Monday that it would change the drug’s label to reflect potential benefits in reducing autism symptoms.

Patients taking the immunotherapy drug Keytruda (pembrolizumab) may now have the option to take it as a quick shot instead of ...

Merck's Keytruda Qlex offers a groundbreaking subcutaneous cancer treatment, enhancing patient convenience with faster ...

The U.S. Food and Drug Administration has approved Merck & Co.’s KEYTRUDA QLEX, a subcutaneous injection for adult patients ...

For the last two years, Keytruda has reigned as the world’s top-selling drug—a distinction under threat with key patent ...